Courage Over Cancer

NIH grant to boost ovarian cancer drug development

The Mays Cancer Center and Evestra Inc., a San Antonio, Texas-based biopharmaceutical company, have been awarded a five-year, $3.3 million Academic Industry Partnership grant from the National Institutes of Health.

Boosting Hispanic representation in cancer research

The Mays Cancer Center has been named a founding partner of the Advancing Inclusive Research Site Alliance, a coalition of clinical research sites seeking to advance the representation of diverse patient populations in clinical trials.